glp-1 indications Medications Infographic View of GLP-1 receptor agonists

Explore evidence, side effect tips, and coordination strategies with nephrology.

At the same time, both Lilly and Novo Nordisk made multi-billion dollar capital investments in expanding their manufacturing capacity to satisfy unrelenting patient demand, including pharmas largest M&A deal of the year, the $16.5Bn acquisition of CDMO Catalent by Novo Holdings, the controlling shareholder of Novo Nordisk

Key Benefits: No injections required

Little is known about the association of discontinuation of sodium-glucose cotransporter-2 (SGLT2) inhibitors and glucagon-like peptide-1 receptor agonists (GLP-1 RA) with outcomes in patients with CKD

GLP-1 therapies reduce inflammation across organs through rapid, weight-independent immune and metabolic effects.

Access practical tips to manage GLP-1 side effects, reduce discomfort, and stay consistent with your treatment plan.